Study Completed

Hormone replacement therapy (HRT)

Bayer Identifier:

13300

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

2008-004693-40

EU CT Number:

Not Available

Angeliq low/low: MD PK

Trial purpose

Please see attached Study Results Summary below

Key Participants Requirements

Sex

N/A

Age

45 - 75 Years

Trial summary

Enrollment Goal

Trial Dates

April 2009 - July 2009

Phase

Phase 1

Could I Receive a placebo

N/A

Products

Low-Dose E2/DRSP (BAY86-4891)

Accepts Healthy Volunteer

N/A

Where to participate

Status	Institution	Location
Completed	Bayer Schering Pharma AG	Berlin, 13353, Germany

Trial design

Open-label, randomized, mono-center study to investigate the pharmacokinetics of 17beta-estradiol (E2) and drospirenone (DRSP) after multiple oral administration of 2 tablet formulations containing 0.5 mg E2 in combination with either 0.5 or 0.25 mg DRSP in 24 healthy postmenopausal women

Trial Type

Interventional

Intervention Type

N/A

Trial Purpose

N/A

Allocation

N/A

Blinding

N/A

Assignment

N/A

Trial Arms

N/A

Additional Information

Click here and search for drug information provided by the FDA.Click here and search for information on any recalls, market or product safety alerts by the FDA which might have occurred with this product.